Laboratory Of Stock EBITDA
| LH Stock | USD 240.17 2.32 0.98% |
Laboratory of fundamentals help investors to digest information that contributes to Laboratory's financial success or failures. It also enables traders to predict the movement of Laboratory Stock. The fundamental analysis module provides a way to measure Laboratory's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Laboratory stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 1.3 B | 1.1 B |
Laboratory | EBITDA |
Laboratory of Company EBITDA Analysis
Laboratory's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Laboratory EBITDA | 1.35 B |
Most of Laboratory's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratory of is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Laboratory EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Laboratory is extremely important. It helps to project a fair market value of Laboratory Stock properly, considering its historical fundamentals such as EBITDA. Since Laboratory's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Laboratory's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Laboratory's interrelated accounts and indicators.
Click cells to compare fundamentals
Laboratory EBITDA Historical Pattern
Today, most investors in Laboratory Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Laboratory's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Laboratory ebitda as a starting point in their analysis.
Laboratory EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Laboratory Ebitda
Ebitda |
|
According to the company disclosure, Laboratory of reported earnings before interest,tax, depreciation and amortization of 1.35 B. This is 53.79% higher than that of the Health Care Providers & Services sector and 288.99% higher than that of the Health Care industry. The ebitda for all United States stocks is 65.39% higher than that of the company.
Laboratory EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.Laboratory is currently under evaluation in ebitda category among its peers.
Laboratory ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.Environmental | Governance | Social |
Laboratory Institutional Holders
Institutional Holdings refers to the ownership stake in Laboratory that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Laboratory's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Laboratory's value.| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.4 M | Amvescap Plc. | 2024-06-30 | 1.3 M | Veritas Investment Partners (uk) Ltd. | 2024-09-30 | 1.2 M | Norges Bank | 2024-06-30 | 1 M | Northern Trust Corp | 2024-09-30 | 1 M | Nordea Investment Mgmt Bank Demark A/s | 2024-09-30 | 984 K | Bank Of America Corp | 2024-06-30 | 978.1 K | Cooke & Bieler Lp | 2024-09-30 | 942.1 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 914 K | Vanguard Group Inc | 2024-09-30 | 9.6 M | Blackrock Inc | 2024-06-30 | 9.5 M |
Laboratory Fundamentals
| Return On Equity | 0.0543 | ||||
| Return On Asset | 0.0396 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 26.29 B | ||||
| Shares Outstanding | 83.64 M | ||||
| Shares Owned By Insiders | 0.32 % | ||||
| Shares Owned By Institutions | 94.81 % | ||||
| Number Of Shares Shorted | 2.03 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 1.58 X | ||||
| Revenue | 12.16 B | ||||
| Gross Profit | 4.39 B | ||||
| EBITDA | 1.35 B | ||||
| Net Income | 379.2 M | ||||
| Cash And Equivalents | 430 M | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 5.95 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 97.61 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Short Ratio | 3.53 X | ||||
| Earnings Per Share | 5.26 X | ||||
| Price To Earnings To Growth | 0.51 X | ||||
| Target Price | 261.25 | ||||
| Number Of Employees | 67 K | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 20.09 B | ||||
| Total Asset | 16.73 B | ||||
| Retained Earnings | 7.89 B | ||||
| Working Capital | 540.2 M | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 16.73 B | ||||
| Last Dividend Paid | 2.88 |
About Laboratory Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.26 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.